405 Obesity Medicine, GLP1 agonists, Weight Loss Management Tools and Tips  - The Curbsiders

405 Obesity Medicine, GLP1 agonists, Weight Loss Management Tools and Tips - The Curbsiders

Price: $ 9.00

4.5(758)

Hone your obesity medicine skills in primary care! We discuss overcoming barriers, patient counseling, obesity pathophysiology, motivational interviewing, tools and tips from a weight loss program, and how to discuss medications for weight loss including phentermine/topiramate, bupropion/naltrexone, orlistat, oral superabsorbent hydrogel, and GLP1 agonists. We’re joined by obesity medicine expert, Dr. Kimberly Anne Gudzune of

https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/original_images/Anti-obesity_graphic_500.jpg

Anti-obesity drugs are closing the gap between dieting and bariatric surgery, Diet and Nutrition, Prevention

https://i.ytimg.com/vi/u_KJxELIE9s/maxresdefault.jpg

Advances in Obesity Medicine, Emphasis on Cardiovascular Health - Grand Rounds

https://source.boomplaymusic.com/group10/M00/12/18/cf4eb0c1646e43558752ee9792dc9998_320_320.jpg

Curbsiders TEACH is Coming Soon!, Podcast

https://assets.delveinsight.com/blog/wp-content/uploads/2023/03/16120644/Promising-Emerging-MoAs-for-Obesity-Management.png

Potential Emerging Therapies in the Obesity Treatment Space

https://i.ytimg.com/vi/Iq7n3cJKpq8/hqdefault.jpg

4 Things you need to know about the new GLP1 weight loss medications

https://m3.healio.com/~/media/slack-news/cardiology/misc/infographics/2023/08_august/ct0823healioexclusive_august_graphic_02_web.jpg

Game changing' data: New obesity drugs tied to major weight loss, may reduce CV risk

https://thecurbsiders.com/wp-content/uploads/2023/08/16-Inpatient-AWS-300x300.png

assistant - The Curbsiders

https://podcast-api-images.s3.amazonaws.com/corona/show/305605/logo.png

The Curbsiders Internal Medicine Podcast podcast - Free on The Podcast App

https://audioboom.com/i/40571518

The Curbsiders Internal Medicine Podcast / #396 Recap, Top Pearls from #SGIM23

https://audioboom.com/i/39366240/s=1400x1400/el=1/rt=fill.png

342 Checkpoint Inhibitors: The power, and adverse effects, of immunotherapy (ACP 2022) – The Curbsiders Internal Medicine Podcast – Podcast – Podtail

https://images.squarespace-cdn.com/content/v1/54fcabf1e4b05f6987ac7401/668f8686-b415-4e8b-98f6-3484e3ada4d8/Screen+Shot+2023-04-30+at+1.58.41+PM.png

The GLP-1 Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy

https://i.ytimg.com/vi/AlWriMdYuKk/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLDiUl7M29MOFu8EanyI2264Z2jnHA

Stephan Guyenet, PhD: GLP-1, Semaglutide, and the Big Future of Weight Loss Therapies

https://i.ytimg.com/vi/EMXkyE8NQAo/maxresdefault.jpg

Changing the Obesity Narrative: Supporting Primary Care to Improve Weight Management